1 Market Overview
1.1 Product Overview and Scope of Anti-obesity Medicine
1.2 Classification of Anti-obesity Medicine by Type
1.2.1 Overview: Global Anti-obesity Medicine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Anti-obesity Medicine Revenue Market Share by Type in 2020
1.2.3 Prescription Drugs
1.2.4 OTC Drugs
1.3 Global Anti-obesity Medicine Market by Application
1.3.1 Overview: Global Anti-obesity Medicine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Men
1.3.3 Women
1.4 Global Anti-obesity Medicine Market Size & Forecast
1.5 Global Anti-obesity Medicine Market Size and Forecast by Region
1.5.1 Global Anti-obesity Medicine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Anti-obesity Medicine Market Size by Region, (2016-2021)
1.5.3 North America Anti-obesity Medicine Market Size and Prospect (2016-2026)
1.5.4 Europe Anti-obesity Medicine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Anti-obesity Medicine Market Size and Prospect (2016-2026)
1.5.6 South America Anti-obesity Medicine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Anti-obesity Medicine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-obesity Medicine Market Drivers
1.6.2 Anti-obesity Medicine Market Restraints
1.6.3 Anti-obesity Medicine Trends Analysis
2 Company Profiles
2.1 Alizyme
2.1.1 Alizyme Details
2.1.2 Alizyme Major Business
2.1.3 Alizyme Anti-obesity Medicine Product and Solutions
2.1.4 Alizyme Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Alizyme Recent Developments and Future Plans
2.2 Amylin Pharmaceuticals
2.2.1 Amylin Pharmaceuticals Details
2.2.2 Amylin Pharmaceuticals Major Business
2.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Product and Solutions
2.2.4 Amylin Pharmaceuticals Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Amylin Pharmaceuticals Recent Developments and Future Plans
2.3 Arena Pharmaceuticals
2.3.1 Arena Pharmaceuticals Details
2.3.2 Arena Pharmaceuticals Major Business
2.3.3 Arena Pharmaceuticals Anti-obesity Medicine Product and Solutions
2.3.4 Arena Pharmaceuticals Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Arena Pharmaceuticals Recent Developments and Future Plans
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business
2.4.3 Boehringer Ingelheim Anti-obesity Medicine Product and Solutions
2.4.4 Boehringer Ingelheim Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Boehringer Ingelheim Recent Developments and Future Plans
2.5 Eisai
2.5.1 Eisai Details
2.5.2 Eisai Major Business
2.5.3 Eisai Anti-obesity Medicine Product and Solutions
2.5.4 Eisai Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Eisai Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Anti-obesity Medicine Product and Solutions
2.6.4 GlaxoSmithKline Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Orexigen Therapeutics
2.7.1 Orexigen Therapeutics Details
2.7.2 Orexigen Therapeutics Major Business
2.7.3 Orexigen Therapeutics Anti-obesity Medicine Product and Solutions
2.7.4 Orexigen Therapeutics Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Orexigen Therapeutics Recent Developments and Future Plans
2.8 Vivus
2.8.1 Vivus Details
2.8.2 Vivus Major Business
2.8.3 Vivus Anti-obesity Medicine Product and Solutions
2.8.4 Vivus Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Vivus Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Anti-obesity Medicine Product and Solutions
2.9.4 Pfizer Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business
2.10.3 Roche Anti-obesity Medicine Product and Solutions
2.10.4 Roche Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Roche Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Anti-obesity Medicine Product and Solutions
2.11.4 Merck Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Merck Recent Developments and Future Plans
2.12 Novo Nordisk
2.12.1 Novo Nordisk Details
2.12.2 Novo Nordisk Major Business
2.12.3 Novo Nordisk Anti-obesity Medicine Product and Solutions
2.12.4 Novo Nordisk Anti-obesity Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Novo Nordisk Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Anti-obesity Medicine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Anti-obesity Medicine Players Market Share
3.2.2 Top 10 Anti-obesity Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 Anti-obesity Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Anti-obesity Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global Anti-obesity Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Anti-obesity Medicine Revenue Market Share by Application (2016-2021)
5.2 Anti-obesity Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Anti-obesity Medicine Revenue by Type (2016-2026)
6.2 North America Anti-obesity Medicine Revenue by Application (2016-2026)
6.3 North America Anti-obesity Medicine Market Size by Country
6.3.1 North America Anti-obesity Medicine Revenue by Country (2016-2026)
6.3.2 United States Anti-obesity Medicine Market Size and Forecast (2016-2026)
6.3.3 Canada Anti-obesity Medicine Market Size and Forecast (2016-2026)
6.3.4 Mexico Anti-obesity Medicine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Anti-obesity Medicine Revenue by Type (2016-2026)
7.2 Europe Anti-obesity Medicine Revenue by Application (2016-2026)
7.3 Europe Anti-obesity Medicine Market Size by Country
7.3.1 Europe Anti-obesity Medicine Revenue by Country (2016-2026)
7.3.2 Germany Anti-obesity Medicine Market Size and Forecast (2016-2026)
7.3.3 France Anti-obesity Medicine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Anti-obesity Medicine Market Size and Forecast (2016-2026)
7.3.5 Russia Anti-obesity Medicine Market Size and Forecast (2016-2026)
7.3.6 Italy Anti-obesity Medicine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Anti-obesity Medicine Revenue by Type (2016-2026)
8.2 Asia-Pacific Anti-obesity Medicine Revenue by Application (2016-2026)
8.3 Asia-Pacific Anti-obesity Medicine Market Size by Region
8.3.1 Asia-Pacific Anti-obesity Medicine Revenue by Region (2016-2026)
8.3.2 China Anti-obesity Medicine Market Size and Forecast (2016-2026)
8.3.3 Japan Anti-obesity Medicine Market Size and Forecast (2016-2026)
8.3.4 South Korea Anti-obesity Medicine Market Size and Forecast (2016-2026)
8.3.5 India Anti-obesity Medicine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Anti-obesity Medicine Market Size and Forecast (2016-2026)
8.3.7 Australia Anti-obesity Medicine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Anti-obesity Medicine Revenue by Type (2016-2026)
9.2 South America Anti-obesity Medicine Revenue by Application (2016-2026)
9.3 South America Anti-obesity Medicine Market Size by Country
9.3.1 South America Anti-obesity Medicine Revenue by Country (2016-2026)
9.3.2 Brazil Anti-obesity Medicine Market Size and Forecast (2016-2026)
9.3.3 Argentina Anti-obesity Medicine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Anti-obesity Medicine Revenue by Type (2016-2026)
10.2 Middle East & Africa Anti-obesity Medicine Revenue by Application (2016-2026)
10.3 Middle East & Africa Anti-obesity Medicine Market Size by Country
10.3.1 Middle East & Africa Anti-obesity Medicine Revenue by Country (2016-2026)
10.3.2 Turkey Anti-obesity Medicine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Anti-obesity Medicine Market Size and Forecast (2016-2026)
10.3.4 UAE Anti-obesity Medicine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
【掲載企業】
Alizyme、Amylin Pharmaceuticals、Arena Pharmaceuticals、Boehringer Ingelheim、Eisai、GlaxoSmithKline、Orexigen Therapeutics、Vivus、Pfizer、Roche、Merck、Novo Nordisk
【免責事項】
https://www.globalresearch.jp/disclaimer